MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$79.61

Market cap

$105.92B

P/E Ratio

26.1

Dividend/share

$2.67

EPS

$3.05

Enterprise value

$129.52B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
The price to earnings (P/E) is 23% lower than the 5-year quarterly average of 33.9
Medtronic's quick ratio has decreased by 37% YoY
The net income has contracted by 17% YoY and by 6% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.33B
Market cap
$105.92B
Enterprise value
$129.52B
Valuations
Price to earnings (P/E)
26.1
Price to book (P/B)
2.06
Price to sales (P/S)
3.44
EV/EBIT
21.65
EV/EBITDA
14.91
EV/Sales
4.21
Earnings
Revenue
$30.77B
EBIT
$5.98B
EBITDA
$8.69B
Free cash flow
$4.17B
Per share
EPS
$3.05
Free cash flow per share
$3.13
Book value per share
$38.67
Revenue per share
$23.13
TBVPS
$28.04
Balance sheet
Total assets
$94.13B
Total liabilities
$42.52B
Debt
$28.13B
Equity
$51.44B
Working capital
$10.94B
Liquidity
Debt to equity
0.55
Current ratio
1.76
Quick ratio
1.18
Net debt/EBITDA
2.72
Margins
EBITDA margin
28.2%
Gross margin
66.4%
Net margin
13.2%
Operating margin
18.2%
Efficiency
Return on assets
4.4%
Return on equity
7.8%
Return on invested capital
13.7%
Return on capital employed
7.5%
Return on sales
19.4%
Dividend
Dividend yield
3.35%
DPS
$2.67
Payout ratio
87.5%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
1.69%
1 week
2.09%
1 month
-6.12%
1 year
-27.75%
YTD
2.43%
QTD
2.43%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$30.77B
Gross profit
$20.44B
Operating income
$5.59B
Net income
$4.06B
Gross margin
66.4%
Net margin
13.2%
The net income has contracted by 17% YoY and by 6% from the previous quarter
MDT's net margin is down by 15% year-on-year and by 6% since the previous quarter
MDT's gross profit is down by 5% year-on-year
The operating income has decreased by 4.6% QoQ

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
26.1
P/B
2.06
P/S
3.44
EV/EBIT
21.65
EV/EBITDA
14.91
EV/Sales
4.21
The price to earnings (P/E) is 23% lower than the 5-year quarterly average of 33.9
The EPS has declined by 16% year-on-year and by 6% since the previous quarter
The stock's price to book (P/B) is 24% less than its 5-year quarterly average of 2.7 and 10% less than its last 4 quarters average of 2.3
The company's equity fell by 2.1% YoY
MDT's P/S is 24% lower than its 5-year quarterly average of 4.5 and 12% lower than its last 4 quarters average of 3.9
Medtronic's revenue has decreased by 3.2% YoY

Efficiency

How efficient is Medtronic business performance
Medtronic's return on equity has decreased by 18% YoY and by 4.9% QoQ
MDT's return on assets is down by 17% year-on-year and by 6% since the previous quarter
The company's return on invested capital rose by 10% YoY but it fell by 2.8% QoQ
The return on sales has declined by 3% since the previous quarter but it rose by 2.6% year-on-year

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.67
Dividend yield
3.35%
Payout ratio
87.5%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 121% greater than the total liabilities
Medtronic's quick ratio has decreased by 37% YoY
The company's current ratio fell by 33% YoY
MDT's debt is 45% smaller than its equity
Medtronic's debt to equity has increased by 15% YoY and by 8% from the previous quarter
MDT's debt is up by 12% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.